| Literature DB >> 36160642 |
Jie Yang1, Chun-Lu Tan1, Dan Long2, Yan Liang3, Li Zhou3, Xu-Bao Liu1, Yong-Hua Chen4.
Abstract
BACKGROUND: Solid pseudopapillary tumor (SPT) is a rare pancreatic tumor. Considering its malignant behaviors, SPT has been classified as a low-grade malignant tumor. Indeed, only 9.2% of all SPT patients are initially diagnosed as malignant with invasion or metastasis. Thus, one of the challenges in managing SPT patients is predicting malignant behavior. AIM: To investigate the malignant behavior and tumor-associated macrophage (TAM) infiltration between different histopathologic features of SPT patients.Entities:
Keywords: Histological labeling; Immunohistochemistry; Malignancy; Pancreatic neoplasms; Solid pseudopapillary tumors; Tumor-associated macrophages
Mesh:
Substances:
Year: 2022 PMID: 36160642 PMCID: PMC9494934 DOI: 10.3748/wjg.v28.i34.5047
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.374
Figure 1Computed tomography imaging, specimen and histopathologic features of capsulized and invasive solid pseudopapillary tumors. A, C and E: For the capsulized solid pseudopapillary tumors (SPTs), computed tomography (CT) imaging (A) and specimen (C) showed a clear distinction from surrounding pancreatic tissue, and an intact fibrous envelope on the tumor margin on hematoxylin and eosin (HE)-stained section (E); B, D and F: Invasive SPT was indistinguishable from surrounding normal pancreatic tissue on CT imaging (B) and in the specimen (D), and tumor cells showed infiltrative growth into normal pancreatic tissue on HE-stained section (F). N: Normal pancreas tissue; T: Tumor. *Tumor margin.
Clinical and pathological characteristics between capsule and invasion solid pseudopapillary tumor patients
|
|
|
|
|
| Age, yr (Median, range) | 26 (12, 46) | 36 (15, 65) | 0.146 |
| Sex (Female) | 10 | 8 | 0.586 |
| Positive serum tumor marker | |||
| CA19-9 | 0 | 1 | 1.000 |
| CA125 | 0 | 2 | 0.476 |
| CEA | 0 | 0 | - |
| NSE | 2 | 5 | 0.361 |
| Surgical procedure | - | ||
| Pancreaticoduodenectomy | 1 | 3 | |
| Distal pancreatectomy | 5 | 5 | |
| Total pancreatectomy | 1 | 0 | |
| Central pancreatectomy | 4 | 3 | |
| Combined segmental hepatectomy | 0 | 3 | |
| Tumor size (Median, range) | 4.8 (2.0-8.1) | 4.0 (1.3-8.8) | 0.834 |
| Tumor location | 1.000 | ||
| Head and neck | 6 | 5 | |
| Body and tail | 5 | 6 | |
| Component of the tumor | 0.387 | ||
| Solid | 3 | 6 | |
| Solid and cystic | 8 | 5 | |
| Calcification | 3 | 2 | 1.000 |
| Capsule assessed by CT imaging | 9 | 2 | 0.004 |
| Peripheral organ invasion | 0 | 2 | 0.476 |
| Metastasis | 0 | 4 | 0.045 |
| Lymph node | 0 | 1 | |
| Liver | 0 | 3 | |
| Spleen | 0 | 1 | |
| Ki-67 Index > 3% | 0 | 4 | 0.045 |
1 patient had both spleen and lymph node metastasis.
CEA: Carcino-embryonic antigen; CT: Computed tomography; NSE: Neuron-specific enolase.
Figure 2Invasion group showed increased tumor-associated CD68-positive macrophage infiltration compared with capsule group by immunohistochemical analysis. A-F: Immunohistochemical-stained imaging and analysis of tumor (A-C) and peritumor (D-F) infiltrated with CD68-positive macrophages in representative patients from the capsule (A, D) and invasion (B, E) groups. N: Normal pancreas tissue. bP< 0.01; dP < 0.0001.
Figure 3Invasion group showed increased tumor-associated CD163-positive M2-like macrophage infiltration compared with capsule group by immunohistochemical analysis. A-F: Immunohistochemical-stained images and analysis of tumor (A-C) and peritumor (D-F) tissues infiltrated with CD163-positive M2-like macrophages in representative patients from the capsule (A, D) and invasion (B, E) groups. N: Normal pancreas tissue. dP < 0.0001.
Figure 4Tumor-associated macrophage infiltration in liver metastasis sites of solid pseudopapillary tumor patients. A and B: Hematoxylin-eosin staining of the liver metastasis site of representative solid pseudopapillary tumor (SPT) patients; C-H: Immunohistochemical-stained imaging and analysis of intratumor and peritumor CD68 (C-E) and CD163 (F-H) expression in the liver metastasis site of representative SPT patients. N: Normal hepatic tissue; NS: No significance.